WO2003081256A3 - Diagnostics et therapeutique pour des maladies associees au recepteur 21 orphelin couple a la proteine g humain (gpr21) - Google Patents
Diagnostics et therapeutique pour des maladies associees au recepteur 21 orphelin couple a la proteine g humain (gpr21) Download PDFInfo
- Publication number
- WO2003081256A3 WO2003081256A3 PCT/EP2003/002405 EP0302405W WO03081256A3 WO 2003081256 A3 WO2003081256 A3 WO 2003081256A3 EP 0302405 W EP0302405 W EP 0302405W WO 03081256 A3 WO03081256 A3 WO 03081256A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gpr21
- diseases
- human
- therapeutics
- diagnostics
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003219030A AU2003219030A1 (en) | 2002-03-22 | 2003-03-10 | Diagnostics and therapeutics for diseases associated with human g protein-coupled orphan receptor 21 (gpr21) |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02006593 | 2002-03-22 | ||
EP02006593.4 | 2002-03-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003081256A2 WO2003081256A2 (fr) | 2003-10-02 |
WO2003081256A3 true WO2003081256A3 (fr) | 2004-03-04 |
Family
ID=28051727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/002405 WO2003081256A2 (fr) | 2002-03-22 | 2003-03-10 | Diagnostics et therapeutique pour des maladies associees au recepteur 21 orphelin couple a la proteine g humain (gpr21) |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003219030A1 (fr) |
WO (1) | WO2003081256A2 (fr) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999028493A2 (fr) * | 1997-12-01 | 1999-06-10 | Smithkline Beecham P.L.C. | Nouveau procede |
WO2000006597A2 (fr) * | 1998-07-31 | 2000-02-10 | Arena Pharmaceuticals, Inc. | Recepteurs orphelins endogenes a activation constitutive couples a la proteine g |
WO2002026824A2 (fr) * | 2000-09-27 | 2002-04-04 | Bristol-Myers Squibb Company | Nouveau recepteur humain couple a la proteine g, hgprbmy5, hautement exprime dans les tissus du cerveau et des ovaires |
-
2003
- 2003-03-10 WO PCT/EP2003/002405 patent/WO2003081256A2/fr not_active Application Discontinuation
- 2003-03-10 AU AU2003219030A patent/AU2003219030A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999028493A2 (fr) * | 1997-12-01 | 1999-06-10 | Smithkline Beecham P.L.C. | Nouveau procede |
WO2000006597A2 (fr) * | 1998-07-31 | 2000-02-10 | Arena Pharmaceuticals, Inc. | Recepteurs orphelins endogenes a activation constitutive couples a la proteine g |
WO2002026824A2 (fr) * | 2000-09-27 | 2002-04-04 | Bristol-Myers Squibb Company | Nouveau recepteur humain couple a la proteine g, hgprbmy5, hautement exprime dans les tissus du cerveau et des ovaires |
Also Published As
Publication number | Publication date |
---|---|
AU2003219030A8 (en) | 2003-10-08 |
AU2003219030A1 (en) | 2003-10-08 |
WO2003081256A2 (fr) | 2003-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003082314A3 (fr) | Diagnostics et therapies pour maladies liees a un recepteur de type 1 de peptides n-formyl (fprl1) | |
WO2003081258A3 (fr) | Diagnostics et elements therapeutiques pour maladies associees au recepteur secretagogue de l'hormone de croissance (ghs) | |
WO2003074069A3 (fr) | Diagnostic et therapeutique destines a des maladies associees au recepteur peptidique n-formyl 1 (fpr1) | |
WO2004042389A3 (fr) | Moyens diagnostiques et therapeutiques destines a des maladies associees a la phosphodiesterase 4d (pde4d) humaine | |
WO2005095972A3 (fr) | Composes destines au diagnostic et au traitement de maladies associees au recepteur couple aux proteines g etb (etb) | |
WO2003093816A3 (fr) | Diagnostics et therapeutiques pour lutter contre des maladies associees au recepteur de l'oxytocine (oxtr) | |
WO2003065044A8 (fr) | Agents diagnostiques et therapeutiques destines a des maladies associees a gpr72 | |
WO2004042402A3 (fr) | Moyens diagnostiques et therapeutiques destines a des maladies associees au mrgx1 humain | |
WO2003095967A3 (fr) | Methodes diagnostiques et therapeutiques pour les maladies associees au recepteur 9 des chimiokines (ccr9) | |
WO2004038405A3 (fr) | Diagnostics et therapeutiques pour maladies liees au recepteur 43 couple a la proteine g (gpr43) | |
WO2003081256A3 (fr) | Diagnostics et therapeutique pour des maladies associees au recepteur 21 orphelin couple a la proteine g humain (gpr21) | |
WO2004071378A3 (fr) | Methodes diagnostiques et therapeutiques relatives a des etats pathologiques lies au recepteur hm74a couple a la proteine g | |
WO2003083135A3 (fr) | Diagnostique et therapie de maladies associees au recepteur 2 du neuropeptide ff (npff2) | |
WO2004038421A3 (fr) | Agents diagnostiques et therapeutiques pour maladies associees au recepteur 41 couple a une proteine g humaine (gpr41) | |
WO2003081257A3 (fr) | Moyens diagnostiques et therapeutiques pour lutter contre des maladies associees au recepteur 1 du neuropeptide ff (npff1) | |
WO2003080099A3 (fr) | Diagnostics et traitements de maladies associees au recepteur 10 couple aux proteines g (gpr10) | |
WO2004042405A3 (fr) | Diagnostic et therapeutique pour maladies associees au recepteur 3 couples aux proteines g (gpr3) humain | |
WO2003100433A3 (fr) | Diagnostics et therapies pour maladies liees au recepteur 3 de l'arginine vasopressine (avpr3) | |
WO2003080100A3 (fr) | Diagnostic et therapie des maladies associees au recepteur 63 couple a la proteine g chez homo sapiens (gpr63) | |
WO2003066077A3 (fr) | Outil de diagnostic et therapeutique pour des maladies associees au recepteur de neuromedine u1 (nmu1) | |
WO2003096020A3 (fr) | Diagnostic et traitement de maladies liees au recepteur 8 des chimiokines (ccr8) | |
WO2004015427A3 (fr) | Methodes diagnostiques et therapeutiques s'adressant a des maladies associees au recepteur 19 couple a la proteine g (gpr19) | |
WO2004038416A8 (fr) | Diagnostic et therapeutique de maladies associees au recepteur 6 couple a la proteine g humain (gpr6) | |
WO2004015422A3 (fr) | Diagnostic et traitement de maladies associees au recepteur 1 couple a la proteine g (ogr-1) du cancer de l'ovaire | |
WO2004038406A3 (fr) | Diagnostic et therapie de maladies associees au recepteur 42 couple a la proteine g (gpr42) humain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |